Work Here?
Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This technology can identify and fix faulty DNA segments, which helps restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Unlike many competitors, Prime Medicine emphasizes collaboration with research institutions and pharmaceutical companies to advance its technology and bring it to market. Their business model includes licensing agreements and partnerships, which helps them generate revenue. The leadership team, including experienced professionals like Chief Technical Officer Ann L. Lee, is dedicated to enhancing the company's technological capabilities and scaling operations.
Company Stage
IPO
Employees
201-500
Industries
Biotechnology, Healthcare
Total Funding
$306.4M
Headquarters
Cambridge, Massachusetts
Founded
2019
Help us improve and share your feedback! Did you find this helpful?
Find jobs on Simplify and start your career today